August 19, 2025
Read
August 19, 2025

How Fast Do Tumours Really Grow?

How Fast Do Tumours Really Grow?

Contents

Table of contents placeholder

There’s a common misconception that all tumours grow at the same rate, but that’s not the case. The growth of tumours largely depends on the type of tumour, genetics, and the organs it affects. Imaging tests are essential for early detection of tumours, especially fast-growing, aggressive tumours, as this is the only way to monitor tumour growth before it becomes dangerous. This blog will outline the science behind tumour growth, give insights into aggressive and fast-growing tumours, and explain how early detection can help you stay ahead and be proactive about your health.

What Does It Mean When a Tumour Is “Fast-Growing”? 

Tumour Doubling Time 

The time it takes for tumours to double in size typically depends on the type of tumour1. Fast-growing tumours tend to double in days to weeks, whereas slow-growing tumours may take months to years. Take the example of small-cell lung cancer vs. prostate cancer. Small-cell lung cancer tends to grow much faster, having a doubling time of approximately 30-200 days, whereas prostate cancers are much slower growing, taking 2 - 4 years for their growth to double2,3.

What’s Considered a Fast-Growing Tumour? 

For some tumours, a doubling time of around 30 days is considered fast-growing4. Even with aggressive and fast-growing forms of cancer, fast intervention and early detection can lead to significantly better outcomes1. Knowing the growth rates of tumours using imaging techniques like computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans is vital to guide treatment timelines and monitor how well tumours respond to treatment. 

How Fast Do Tumours Actually Grow?

How quickly a tumour grows varies significantly from patient to patient, even in those with the same type of cancer1. Tumours can develop from just a few millimetres to life-threatening sizes in less than a year. The concerning thing is, this rapid growth is exponential rather than linear, meaning that the tumour can double in size as time progresses.

Diagram of how cancer cells grow and double over time. Source; designed by Freepik.

Why Size and Not Just Stage Matters in Cancer Progression 

Tumour size is an important factor that directly influences the prognosis, treatment options, and surgical outcomes across many different types of cancer. Generally, smaller tumours are associated with better survival rates and outcomes, whereas larger tumours often come with a poorer prognosis because of limited treatment options. Cancers like breast, hepatocellular carcinoma, and colorectal, with tumours of less than 2 centimetres, have higher survival rates as they can usually be surgically removed at earlier stages5,6. Although tumour size doesn’t always reflect how aggressive a cancer is, or whether it has spread. Some small tumours may have already spread to other parts of the body (metastasised), and others may grow large but stay localised to one area1.

Many people wonder how long it takes for cancer to progress from stage I to IV. This largely depends on the type of cancer, but for aggressive cancers like small-cell lung cancer and lymphoma, it can be months1. Whereas for slower-growing cancers, it could be years. This is why it’s important to speak to your healthcare provider as soon as symptoms arise, as early screening and detection could prevent tumours from growing and spreading while being undetected. 

The Most Aggressive Cancers and How Fast They Can Grow 

Recognising which cancers grow the fastest and the speed at which they can progress highlights the importance of early detection. Here are some examples of the most aggressive and deadliest cancers, categorised by their behaviour, which populations they affect, and their rates of survival. 

Pancreatic Cancer

Growth Pattern: Can quickly spread to nearby organs such as the liver. Often, pancreatic cancer has minimal early symptoms, so it is usually only detected at a late stage.

Time from Stage I to IV: Progression of pancreatic cancer can be very fast, occurring in under a year for many patients7.

Survival Rate (5-year): Around 12 percent, highlighting its poor prognosis even with treatment7.

Common In: Both men and women can be affected, with most diagnoses occurring in patients over 60 years old7.

Small-Cell Lung Cancer

Growth Pattern: Can spread extremely fast with a doubling time of 30-200 days, alongside high chances of metastasis, particularly to the brain and bones3.

Time from Stage I to IV: Progression can be in as little as 2-4 months due to its rapid growth and aggressive nature8.

Survival Rate (5-year):  Around 5-10 percent, reflecting its poor prognosis9.

Common In: Primarily older adult smokers, with men being slightly more susceptible9.

Glioblastoma (Brain Cancer)

Growth Pattern: Can spread to surrounding brain tissue quickly, making surgical removal difficult10.

Time from Stage I to IV: Progression in patients with symptoms can sometimes be weeks to months10.

Survival Rate (5-year): Around 5 percent, glioblastoma is one of the most aggressive forms of 11.

Common In: The chances of males developing this form of aggressive cancer are 1.5 times higher than for females, and often leads to poorer outcomes12,13.

Triple-Negative Breast Cancer (TNBC)

Growth Pattern: TNBC is an aggressive subtype of breast cancer that lacks oestrogen, progesterone, and HER2 (hormone) receptors. This limits treatment options, leading to fast progression with poorer outcomes compared to other forms of breast cancer14,15.

Time from Stage I to IV: Progression can be 8-13 months due to its fast growth and likelihood of metastasis16.

Survival Rate (5-year): Taking into account all stages, the 5-year survival rate is 77 percent, with early prognosis and lack of metastasis leading to much better survival rates17.

Common In: TNBC is one of the most aggressive cancers in females, and black females are over 2 times more at risk of developing TNBC18. Carriers of the BRCA1 gene have a 72 percent risk of developing breast cancer compared to 12 percent in the general population19.

Liver Cancer (Hepatocellular Carcinoma)

Growth Pattern: Around 25 percent of hepatocellular carcinomas are fast growing, with doubling times ranging from 3 - 8 months20. Cirrhosis (liver scarring and damage) from hepatitis B and C and alcohol-related issues may lead to the development of more aggressive disease20,21.

Time from Stage I to IV: Often within a year, patients with cirrhosis or chronic viral hepatitis are more susceptible to faster disease advancement21.

Survival Rate (5-year): Around 15 percent22.

Common In: Males are more susceptible than females, especially those with hepatitis or alcohol-related liver disease21.

MRI scans of females with different types of breast cancer. Adapted from Source and published under the Creative Commons License.

Why These Cancers Are So Dangerous 

Silent Until It’s Too Late 

Often, pancreatic, liver, and ovarian cancers have no early symptoms and are left undetected until late-stage. By the time symptoms are present, these cancers have usually spread to other parts of the body. Early screening helps you catch these cancers, even before symptoms appear.

Why Aggressive Doesn’t Always Mean Incurable

Aggressive and fast-growing cancers can be treated if caught early, leading to much better outcomes. At Ezra, we offer a full-body MRI scan, which enables early identification of abnormalities across 14 organs. If you are experiencing symptoms of cancer or are at a high risk of developing cancer, speak to your healthcare provider and consider booking in for our full-body MRI scan.

How Early Detection Changes the Game 

Early detection is the only way to track tumour growth. An MRI scan can screen for abnormalities even when they’re at just a few millimetres, before symptoms appear and before the cancer spreads. Ezra scans use radiation-free, AI-enhanced imaging to deliver safe and fast results. Baseline imaging helps screen for differences between scans, helping you and your healthcare provider have a clear comparison of any changes.

FAQs 

How fast can cancer grow without symptoms?

Many types of cancer can grow for months or years without causing any symptoms, this depends on the type of cancer, its growth rate, and location1–3.

Can Ezra’s MRI detect aggressive cancers?

Yes, Ezra’s MRI can screen for abnormalities, including even aggressive types of cancers.

Do fast-growing tumors always mean worse outcomes?

Not always, fast-growing tumours are usually more aggressive and more likely to spread to other parts of the body, but early detection and treatment can still improve prognosis1.

Is colon cancer fast-growing? 

Typically, colon cancer is slow-growing, but some subtypes may grow more quickly1.

Is pancreatic cancer fast-growing?

Pancreatic cancer is generally fast-growing. Usually, progression from early stage to late stage happens in around a year7.

Is prostate cancer fast-growing?

Most prostate cancers are slow-growing and don’t cause any symptoms for many years1. Some more aggressive subtypes can progress more quickly.

Is kidney cancer fast-growing? 

This depends on the type of kidney cancer – some types can be slow-growing without symptoms for many years, but some can progress quickly1.

Is rectal cancer fast-growing? 

Rectal cancer is typically slow-growing, but some subtypes may grow more quickly1.

Is bladder cancer fast-growing? 

This depends on the type of bladder cancer and whether it has spread to muscle23. Non-muscle invasive (has not spread) bladder cancers are typically slower growing than bladder cancers that are muscle invasive23.

Is liver cancer fast-growing? 

Typically, liver cancer is fast-growing, especially in patients who have cirrhosis or chronic liver disease20,21

Is breast cancer fast-growing? 

Usually, breast cancer is slow-growing and may not cause any symptoms for years, but subtypes like TNBC can grow and spread more quickly15.

Is thyroid cancer fast-growing? 

Thyroid cancer tends to be slower growing, but some subtypes, like anaplastic thyroid cancer, are fast-growing and significantly more aggressive24.

Is ovarian cancer fast-growing? 

The growth rate of ovarian cancer varies depending on the type – some ovarian cancers grow without any symptoms until they reach an advanced stage1.

Ezra offers fast, non-invasive full-body MRI scans that can detect abnormalities in up to 14 organs. Take control of your health with early detection—book your Ezra Scan today.

Understand your risk for cancer with our 5 minute quiz.

Our scan is designed to detect potential cancer early.

References

1. How Quickly Does Cancer Spread? City of Hope. January 12, 2023. Accessed August 12, 2025. https://www.cancercenter.com/community/blog/2023/03/how-quickly-does-cancer-spread 

2. Schmid HP, McNeal JE, Stamey TA. Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer. 1993;71(6):2031-2040. doi:10.1002/1097-0142(19930315)71:6<2031::aid-cncr2820710618>3.0.co;2-q 

3. Harris K, Khachaturova I, Azab B, et al. Small Cell Lung Cancer Doubling Time and its Effect on Clinical Presentation: A Concise Review. Clin Med Insights Oncol. 2012;6:199-203. doi:10.4137/CMO.S9633 

4. Roberts K. How quickly do tumours grow? Cancer Research UK - Cancer News. October 18, 2018. Accessed August 12, 2025. https://news.cancerresearchuk.org/2018/10/18/science-surgery-how-quickly-do-tumours-develop/ 

5. Kong J, Cao Y, Chai J, et al. Effect of Tumor Size on Long-Term Survival After Resection for Solitary Intrahepatic Cholangiocarcinoma. Front Oncol. 2021;10. doi:10.3389/fonc.2020.559911 

6. Chen Z, Zheng H, Zeng W, Liu M, Chen Y. Prognostic Analysis on Different Tumor Sizes for 14634 Hepatocellular Carcinoma Patients. Eur J Cancer Care (Engl). 2023;2023(1):1106975. doi:10.1155/2023/1106975 

7. Pancreatic cancer. Accessed August 12, 2025. https://patient.info/cancer/pancreatic-cancer 

8. Basumallik N, Agarwal M. Small Cell Lung Cancer. In: StatPearls. StatPearls Publishing; 2025. Accessed August 12, 2025. http://www.ncbi.nlm.nih.gov/books/NBK482458

9. Small Cell Lung Cancer Treatment (PDQ®) - NCI. May 14, 2025. Accessed August 12, 2025. https://www.cancer.gov/types/lung/hp/small-cell-lung-treatment-pdq 

10. Ma Z, Niu B, Phan TA, et al. Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients. Sci Rep. 2020;10(1):6642. doi:10.1038/s41598-020-63394-w 

11. Survival for brain tumours. Accessed August 12, 2025. https://www.cancerresearchuk.org/about-cancer/brain-tumours/survival 

12. Brown NF, Ottaviani D, Tazare J, et al. Survival Outcomes and Prognostic Factors in Glioblastoma. Cancers. 2022;14(13):3161. doi:10.3390/cancers14133161 

13. Carrano A, Juarez JJ, Incontri D, Ibarra A, Cazares HG. Sex-Specific Differences in Glioblastoma. Cells. 2021;10(7):1783. doi:10.3390/cells10071783 

14. de Ruijter TC, Veeck J, de Hoon JPJ, van Engeland M, Tjan-Heijnen VC. Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol. 2010;137(2):183-192. doi:10.1007/s00432-010-0957-x 

15. Triple negative breast cancer. Breast Cancer Now. Accessed August 12, 2025. https://breastcancernow.org/about-breast-cancer/diagnosis/types-of-breast-cancer/triple-negative-breast-cancer 

16. Kesireddy M, Elsayed L, Shostrom VK, et al. Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis. Cancers. 2024;16(10):1791. doi:10.3390/cancers16101791 

17. PhD PM. Triple-Negative Breast Cancer: Treatment, Symptoms, Research | BCRF. Breast Cancer Research Foundation. February 21, 2025. Accessed August 12, 2025. https://www.bcrf.org/about-breast-cancer/triple-negative-breast-cancer-treatment-symptoms-research/ 

18. Jack RH, Davies EA, Renshaw C, et al. Differences in breast cancer hormone receptor status in ethnic groups: a London population. Eur J Cancer Oxf Engl 1990. 2013;49(3):696-702. doi:10.1016/j.ejca.2012.09.012 

19. Frost DA. BRCA1 and BRCA2 — Knowledge Hub. GeNotes. Accessed August 12, 2025. https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/brca1-and-brca2/ 

20. Rich NE, John BV, Parikh ND, et al. Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis. Hepatol Baltim Md. 2020;72(5):1654-1665. doi:10.1002/hep.31159 

21. Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primer. 2021;7(1):6. doi:10.1038/s41572-020-00240-3 

22. Survival for liver cancer. Accessed August 12, 2025. https://www.cancerresearchuk.org/about-cancer/liver-cancer/survival 

23. Types of bladder cancer. Accessed August 12, 2025. https://www.cancerresearchuk.org/about-cancer/bladder-cancer/types-stages-grades/types 

24. Survival for thyroid cancer. Accessed August 12, 2025. https://www.cancerresearchuk.org/about-cancer/thyroid-cancer/survival